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In familial hidradenitis suppurativa (HS), mutations in the genes encoding three subunits of the -
secretase complex, PSEN1, PSENEN and NCSTN, have pointed to an impaired NOTCH signalling 
as a pathogenic disease mechanism.1 
Dowling Degos Disease (DDD; MIM 179850, 615327, and 615696)―a rare reticulated 
pigmentary disorder― has also been associated with a deficient NOTCH signalling and patients 
with mutations in PSENEN suffering from both disorders seem to confirm a potential link between 
two apparently different conditions.2-3 However, why mutations in PSENEN cause DDD, HS or 
the combined HS-DDD phenotype, and why mutations in NCSTN have never been associated to 
DDD is not yet understood. 
In this study, we describe a patient with familial HS and concomitant DDD harbouring―a novel 
nonsense mutation in NCSTN associated with a reduced quantity of critical subunits of the γ-
secretase. 
A 54-year-old male patient, with a diagnosis of HS and Hurley II stage disease, was examined for 
recurrent inflammatory lesions affecting the inguinal and genital regions. He reported a HS family 
history (father and daughter). In addition, physical examination showed a typical reticulated 
flexural pigmentation, localized on the scrotum and inguinal crease. Histopathological 
examination of lesional skin confirmed classic DDD diagnosis (Figure 1a). Onset of HS lesions 
was reported at the age of 25 years, while first signs of flexural hyperpigmentation were reported 
at the age of 40 years. The patient never smoked, had a normal Body Mass Index (BMI) and no 
other comorbidities. 
Patient’s DNA was extracted from saliva. We sequenced, with the Sanger method, using exon 
flanking intronic primers, all coding regions of genes associated to DDD: KRT5 (9 exons), 
POGLUT1 (11 exons), POFUT1 (7 exons) and PSENEN (4 exons). We identified only two 
missense single–nucleotide variation in KRT5, both reported as benign in ClinVar. 
Since the proband suffered from HS, we sequenced the coding region of NCSTN (17 exons): a 
single–nucleotide variation in NCSTN exon 15 (NM_015331.2:c.1747C>T), coding for a 
premature stop codon (NP_056146.1:p.(R583*)), was detected (Figure 1c). This genetic variant 
was not present in the Genome Aggregation Database (gnomAD) v.2.1.1. Subsequently, we 
sequenced NCSTN from his 30-year old HS-affected daughter (Figure 1b) and his clinically 
healthy son, observing only in the daughter a co-segregation of the NCSTN heterozygous single–
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Interestingly, physical examination of the patient’s daughter did not reveal any signs of DDD 
disease.
As the substitution encoded for a premature stop codon, we wondered whether the mutation could 
cause haploinsufficiency following nonsense-mediated RNA decay (NMD) of NCSTN. To confirm 
this, we compared NCSTN expression by outer root sheath (ORS) cells isolated from the patient’s 
plucked hairs and those of the healthy son.
It has been reported that NCSTN is dispensable for NOTCH receptors processing by γ-secretase, 
so we questioned whether NCSTN haploinsufficiency could lead to γ-secretase complex instability 
and degradation of its subunits. To verify this, we studied the PEN2, PSEN1 (N-ter and C-ter 
fragments), and PSEN2 expression in ORS cells extracts. After normalization with Beta-Actin, we 
observed that the quantity of these subunits was significantly diminished in ORS cells from our 
patient compared with the healthy son (p<0.05; unpaired t-test; Figure 1d).
The combined HS-DDD phenotype has been reported in different families and case-series. Their 
PSENEN mutations have been associated with HS, HS/DDD or isolated DDD.2-4 Most of the 
pathogenic variants in PSENEN are nonsense or frameshift mutations causing an 
haploinsufficiency of PEN2 either by its proteasomal degradation or by NMD.2 
We further expanded the spectrum of the combined HS/DDD phenotype, reporting the novel role 
of NCSTN and suggesting a putative link between auto-inflammatory and pigmentary disorders. 
Interestingly, the NCSTN mutation of our patient affected PEN2 quantity, mimicking its 
haploinsufficiency. Preliminary experimental evidence suggests a role of NCSTN deficiency in 
pigmentary disorders, by modulating melanosome degradation.5
In autoinflammatory conditions, such as HS, NCSTN, haploinsufficiency seems to stimulate the 
proliferation, type I-interferon gene expression and TNF-alpha induced inflammatory response of 
keratinocytes.6 The fact that our patient has managed to control skin inflammation avoiding well-
known risk-factors could have helped to detect the DD phenotype, which could arise late in life.7 
The affected daughter did not present any clinical signs of DDD yet, which might develop at a 
later age, as observed in her father. The clinical and genetic overlap of HS-DDD may also have a 
clinical relevance, translating in a personalized therapeutic management, such as the combination 
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Figure legends: 
1a. Dowling Degos Disease: flexural reticulate hyperpigmentation with 
representative dermoscopy and histology 
1b. Family pedigree of the proband, HS individuals are labelled in bold.  
1c. Chromatograms of the heterozygous single–nucleotide variation in NCSTN exon 15 coding for 
a premature stop codon identified in the proband (Patient 1) and HS-affected daughter (Patient 2), 









This article is protected by copyright. All rights reserved
1d. WB analysis of 3 independent cultures of ORS cells isolated from the proband suffering from 
HS and DD and his healthy son. Passage 1 ORS cells were seeded in a 6-well plate, grown to 
confluency and proteins extracted in RIPA buffer. -secretase proteins expression was studied with 
antibodies against NCSTN (clone 716910), PEN2 (D6G8), PSEN2 (D30G3) and PSEN1 N-
ter (E3L9X) and C-ter (D39D1) . Beta-actin was used as loading control. Results from the three 
experiences were pulled and their distribution compared with the unpaired t-test (* : p<0.05; ** : 
p<0.01; *** p<0.001)
A
cc
ep
te
d 
A
rt
ic
le
(b)
54-yrs
30-yrs
(c)
(d)
(a)
Patient 1 Son
Beta-Actin
PSEN2
PSEN1 (N-ter)
PSEN1 (C-ter) 
NCSTNm
NCSTNim
PEN2
30
20
20
10
40
110
kDa
Patient
1
Patient
2
